BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 748780)

  • 1. Characterization of prostate carcinoma lines in the Copenhagen rat.
    Voigt W; Lopez DM
    Natl Cancer Inst Monogr; 1978 Dec; (49):269-73. PubMed ID: 748780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
    Lopez DM; Voigt W
    Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
    Coffey DS; Smolev J; Heston WD; Scott WW
    Natl Cancer Inst Monogr; 1978 Dec; (49):289-91. PubMed ID: 748782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE; Isaacs JT
    Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
    Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunological model for the study of prostate cancer.
    Sharma N; Luo J; Kirschmann DA; O'Malley Y; Robbins ME; Akporiaye ET; Lubaroff DM; Heidger PM; Hendrix MJ
    Cancer Res; 1999 May; 59(10):2271-6. PubMed ID: 10344727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors.
    Shain SA; Boesel RW; Kalter SS; Heberling RL
    J Natl Cancer Inst; 1981 Mar; 66(3):565-74. PubMed ID: 6259402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
    Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
    Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone receptor characterization of several histologic variants of a rat prostatic adenocarcinoma.
    Markland FS; Chopp RT; Cosgrove MD; Howard EB
    J Supramol Struct; 1978; 9(4):509-24. PubMed ID: 750763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An animal model for the study of prostate carcinoma.
    Lubaroff DM; Canfield L; Rasmussen GT; Reynolds CW
    Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat prostate carcinoma 11095-A: profile of organ- and tumor-specific antigens.
    Lande IJ; Feldbush TL; Lubaroff DM; Bonney WW
    Natl Cancer Inst Monogr; 1978 Dec; (49):283-7. PubMed ID: 86165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic studies of prostatic cancer using the R3327 rat model.
    Lubaroff DM; Reynolds CW; Culp DA
    Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and morphological characterization of clonal AXC rat prostate cancer cells.
    Shain SA; Huot RI; Gorelic LS; Smith GC
    Cancer Res; 1984 May; 44(5):2033-42. PubMed ID: 6713398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology and ultrastructure of the R-3327 C-F transplantable prostate tumor of Cophenhagen-Fisher rats.
    Seman G; Myers B; Bowen JM; Dmochowski L
    Invest Urol; 1978 Nov; 16(3):231-6. PubMed ID: 711418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen.
    Noble RL
    Cancer Res; 1980 Oct; 40(10):3547-50. PubMed ID: 7438041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM; Milholland RJ; Rosen F
    Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.